Prostaglandin E1 decreases circulating endothelial cells

Prostaglandins

Volumn 51, Issue 1, 1996, Pages 61-68

  Sinzinger, H ^a,c   Fitscha, P ^a   Kritz, H ^b   Rogatti, Waltraud ^a   O'Grady, J ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

circulating endothelial cells; Endothelium; haemostasis; platelet survival; prostaglandin E1; thrombogenicity

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERIPHERAL VASCULAR DISEASE; SMOKING; THROMBOCYTE LIFESPAN; THROMBOGENICITY; ARTERIOSCLEROSIS; CELL COUNT; CELL SURVIVAL; DRUG EFFECT; METABOLISM; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE; VASCULAR ENDOTHELIUM;

ALPROSTADIL; ARTERIOSCLEROSIS; BLOOD PLATELETS; CELL COUNT; CELL SURVIVAL; ENDOTHELIUM, VASCULAR; HUMANS; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029661998     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-6980(95)00157-3     Document Type: Article

References (15)

1. Hladovec, J., and Rosmann, P. Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats. Thromb Res 3: 665. 1973.
2. Hladovec, J. Endothelial injury by nicotine and its prevention. Experientia 34: 1585. 1978.
3. Hladovec, J. Circulating endothelial cells as a sign of vessel wall lesions. Physiologia bohemoslov 27: 140.1978.
4. Hladovec, J. Vasotropic drugs-a survey based on a unifying concept of their mechanism of action. Arzneimittel Forsch 27: 1073. 1977.
5. David, J. W., Shelton, L., Eigenberg, D.A., Hignite, C.E., and Watanabe, I. S. Comparison of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37: 527. 1985.
6. Gall, A., Kausel, W.; Leithner, C., and Sinzinger, H. Osmotic resistance of human platelets during hemodialysis with and without prostacyclin treatment. In: Int. Istanbul Symp on Haematology (Ulutin, O. and Perkada, B., eds.) Sermet Matbaasi, Kriklareli- Vize, 1981. p 567.
7. 1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in-vivo. Postgrad Med J 63: 245. 1987.
8. Sinzinger, H., Kolbe, H., Strobl-Jäger, E., and Höfer, R. A simple and safe technique for sterile autologous platelet labelling using "Monovette vials". Europ J Nucl Med 9: 320. 1984.
9. Fritz. E., Ludwig, H., Scheithauer, W., and Sinzinger, H. Shortened platelet half-life in multiple myeloma. Blood 68: 514. 1986.
10. Davis, J.W., Shelton, L., Eigenberg, D.A. and Hignite, C.E. Lack of effect of aspirin on cigarette smoke-induced increase in circulating endothelial cells. Haemostasis 7: 66. 1987.
11. Prerovsky, I., and Hladovec, J. Suppression of the desquamating effect of smoking on the human endothelium by hydroxyethylrutosides. Blood Vessels 16: 239. 1979.
12. Higgins, R.S.D., Letsou, G.V., Sanchez, J.A., Eisen, R.N., Smith, G.J.W., Franko, K.L, Hammond, G.L., and Baldiun, G.C. Improved ultrastructural long preservation with prostaglandin Et as donor pretreatment in a primate model of heart-lung transplantation. J Thorac Cardiovasc Surg 105: 965. 1993.
13. Hesse, W.H., and Peskar, B.A. Determination of prostaglandin E, metabolism in porcine tissues and human circulation. Coagulation 1: 60. 1989.
14. 1 in patients with peripheral arterial occlusive disease. Prostaglandins 41: 225. 1991.
15. 1 in der Therapie der peripheren arteriellen Durchblutungsstörung. Wr Klin Wschr 103: 558. 1991.